This Frost & Sullivan research service entitled U.S. Computer-Aided Detection Markets provides a complete market analysis and revenue forecast. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: Total CAD market, Breast CAD market, Thoracic CAD market, Colon CAD market, and Emerging CAD market.
This analysis is available through our Medical Imaging Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:
Total CAD Markets
Breast CAD Markets
Thoracic CAD markets
Colon CAD Market
Emerging CAD MArket
Technologies
The following technologies are covered in this research:
CAD - computer aided detection
CT - Computed Tomography
FFDM - full-field digital mammography
Mammo - mammography
Market Overview
Just about everyone in the market felt it coming, the start of acquisition of smaller tier 2 and 3 CAD developers by large OEMs. Although just about everyone saw it coming, it is unsure how many would have figured that that first significant acquisition would have been of R2 Technology by Hologic, Inc, an OEM partner of the company's ImageChecker technology. What is unclear now is how the acquisition will affect the market in terms of the myriad of partnerships that R2 has established with other OEM imaging giants such as GE Healthcare. As a consequence, the future competitive landscape of the market could be dramatically different than today's.
In 2005, both breast Ultrasound CAD and colon CAD were launched at RSNA, with the first installations expected in 2006. With each new CAD application introduced to the CAD market, the potential size of this market grows exponentially. Given the myriad of body parts and systems that CAD technology could be applied to in the future, as well as the different imaging modalities associated with each, growth in this market could be virtually unstoppable. With the increased use of CT in conjunction with autopsies, the application of CAD may soon extend beyond the grave with the technolgy being used to aid medical examiners in determining cause of death.
In the current market, the useful life of a CAD system can range anywhere from 3 to 7 years on average. Replacement has already begun in the mammogaraphy CAD market, fueled to a good degree by the adoption of digital mammography systems. Despite being significantly newer than mammography CAD, replacement has already been reported in the breast MRI market, as well as fueled by the need for more powerful systems for data storage and analysis. By the end of the forecast period, replacement is forecast to make up a minimum of 10 percent of demand in each individual segment. With replacement expected in full force in the two segments with the most demand by that point, namely the breast MRI CAD segment and the mammography CAD segment, overall replacement in the total CAD market is expected to reach almost 50 percent of demand by 2012.
(0 items)
